Use of natural gums and cellulose derivatives in production of sustained release metoprolol tablets

Drug Delivery: Journal of Delivery and Targeting of Therapeutic Agents

Volumn 13, Issue 2, 2006, Pages 113-119

  Varshosaz, Jaleh ^a   Tavakoli, Nasser ^a   Eram, S Ali ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Carboxymethyl Cellulose; Guar; Hydroxypropylmethyl Cellulose; Metoprolol Tartrate; Sustained Release Tablets; Xanthan

Indexed keywords

CARBOXYMETHYLCELLULOSE; GUAR GUM; HYDROXYPROPYLMETHYLCELLULOSE; METOPROLOL; METOPROLOL TARTRATE; XANTHAN;

ACIDITY; ARTICLE; DRUG SOLUBILITY; MATHEMATICAL MODEL; PRIORITY JOURNAL; SPECTROPHOTOMETRY; SUSTAINED RELEASE FORMULATION; TABLET COMPRESSION;

ADRENERGIC BETA-ANTAGONISTS; CARBOXYMETHYLCELLULOSE; DELAYED-ACTION PREPARATIONS; GALACTANS; MANNANS; METOPROLOL; OXAZINES; PLANT GUMS; POLYSACCHARIDES; POLYSACCHARIDES, BACTERIAL; REGRESSION ANALYSIS; TABLETS; TECHNOLOGY, PHARMACEUTICAL;

EID: 31544441684     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.1080/10717540500313356     Document Type: Article

References (27)

1. Altaf, S. A., Yu, K., Parasrampuria, J., and Friend, D. R. 1998a. Guar gum-based sustained release diltiazem. Pharm. Res. 15(8):1196-1201.
2. Altaf, S. A., Wong, D., Gebert, M., Larrabee, S., Yu K., and Friend, D. R. 1998b. Drug release profiles of swellable hydrocolloid formulations: USP apparatus 2 versus apparatus 3, in vitro correlation. Pharm. Technol. 22:62-70.
3. Banakar, U. V. 1992. Pharmaceautical Dissolution Testing, 1st ed. New York: Marcel Dekker, 191-194.
4. Bhalla, H. L., and Sanzgiri, Y. D. 1987. An improved controlled release tablet of salbutamol sulphate. Ind. J. Pharm. Sci. 49:22-25.
5. Castro, I. A., Tirapegui, J., and Benedicto, M. L. 2003. Effects of diet supplementation with three soluble polysaccharides on serum lipid levels of hypercholesterolemic rats. Food Chem. 80:323-330.
6. Catellani, P. L., Vaona, C., Plazzi, P., and Colombo, P. 1988. Compressed matrices, formulation and drug release kinetics. Acta Pharm.Tech. 34(1):38-41.
7. Chueh, H. R., Zia, H., and Rhodes, C. T. 1995. Optimization of sotalol floating and bioadhesive extended release tablet formulations. Drug Dev. Ind. Pharm. 21(15):1725-1747.
8. Dürig, T., and Fassihi, R. 2002. Guar-based monolithic matrix systems: effect of ionizable and non-ionizable substances and excipients on gel dynamics and release kinetics. J. Control. Rel. 80(1-3):45-56.
9. FDA Guidance for industry. 1997. Dissolution Testing of immediate and Modified Release Solid Oral Dosage Forms. Washingten, DC: U.S. Department of Health and Human Services, Food and Drug Administration, August, page 32.
10. Friend, D. R., Altaf, S. A., Yu, K., and Gerbert, M. 1997. Development of a zero-order nifedipine dosage form using COSRx technology. Proc. Int. Symp. Control. Rel. Bioact. Mater. 24:311-312.
11. 2 and Sd for the development of diltiazem HCl modified-release tablets using a 3(2) factorial design. Drug Dev. Ind. Pharm. 28(1):77-87.
12. Hogan, J. E. 1989. Hydroxypropylmethylcellulose sustained release technology. Drug Dev. Ind. Pharm. 15:975-999.
13. Juarez, H., Rico, G., and Villafuerte, L. 2001. Influence of admixed carboxymethylcellulose on release of 4-aminopyridine from hydroxypropyl methylcellulose matrix tablets. Int. J. Pharm. 216(1-2):115-125.
14. Khullar, P., Khar, R.K., and Agarwal, S.P. 1998. Evaluation of guar gum in the preparation of sustained-release matrix tablets. Drug Dev. Ind. Pharm. 24(11):1095-1099.
15. Krishnaiah, Y.S., Karthikeyan, R.S., Gouri, S.V., and Satyanarayana, V. 2002. Three-layer guar gum matrix tablet formulations for oral controlled delivery of highly soluble trimetazidine dihydrochloride. J. Control. Rel. 81(1-2):45-56.
16. Munday, D.L., and Cox, P.G. 2000. Compressed xanthan and karaya gum matrices: hydration, erosion and drug release mechanisms. Int. J. Pharm. 203:179-192.
17. Rao, K.V.R., Devi, K.P., and Buri, P. 1988. Cellulose matrices for zero-order release of soluble drugs. Drug Dev. Ind. Pharm. 14(15-17):2299-2320.
18. Rao, V.M., Haslam, J.L., and Stella, V.J. 2001. Controlled and complete release of a model poorly water-soluble drug, prednisolone, from hydroxypropyl methylcellulose matrix tablets using (SBE) (7m)-beta-cyclodextrin as a solubilizing agent. J. Pharm. Sci. 90(7):807-816.
19. Ritger, P.L., and Peppas, N.A. 1987a. A simple equation for description of solute release. I. Fickian and non-Fickian release from non-swellable devices in the form of slabs, sphere, cylinders or discs. J. Control. Rel. 59:23-36.
20. Ritger, P.L., and Peppas, N.A. 1987b. A simple equation for description of solute release. II. Fickian and anomalous release from swellable devices. J. Control. Rel. 5:37-42.
21. Sinha, V.R., Mittal, B.R., Bhutani, K.K., and Kumria, R. 2004. Colonic drug delivery of 5-flurouracil: an in vitro evaluation. Int. J. Pharm. 269:101-108.
22. Sujja-areevath, J., Munday, D.L., Cox, P.J., and Khan, K.A. 1998. Relationship between swelling, erosion and drug release from hydrophilic natural gum mini-matrix formulations. Eur. J. Pharm. Sci. 6 :207-217.
23. Talukdar, M.M., Michoel, A., Rombaut, P., and Kinget, R. 1996. Comparative study on xanthan gum and hydroxypropylmethylcellulose as matrices for controlled-release drug delivery. I. Compaction and in vitro drug release behavior. Int. J. Pharm. 129:233-241.
24. Talukdar, M.M., Rombaut, P., and Kinget, R. 1998. The release mechanism of an oral controlled-release delivery system for indomethacin. Pharm. Dev.Technol. 3(1):1-6.
25. USP 25 USP/NF. 2002.United States Pharmacopeia/National Formulary (USP25/NF20).New York: United States Pharmacopeial Convention, 1142-1142.
26. Yu, K., Altaf, S.A., Parasramuria, J., and Friend, D.R. 1997. Sustained release ketoprofen: formulation development. Proc. Int. Symp. Control. Rel. Bioact. Mater. 24:16-17.
27. Yu, K., Gerbert, M., Altaf, S.A., Wong D., and Friend D.R. 1998. Optimization of sustained release diltiazem formulations in man by use of an in vitro/in vivo correlation. J. Pharm. Pharmacol. 50:845-850.